Lynne‐Marie Postovit

University of Alberta

Papers

1

Total Citations

64

H-Index

1

About

Dr. Lynne-Marie Postovit is a leading cancer biologist whose research focuses on the molecular mechanisms driving tumor progression and metastasis, with a particular emphasis on protein lipidation and the tumor microenvironment. Her major contributions include pioneering the therapeutic targeting of N-myristoylation—the N-terminal addition of the fatty acid myristate to proteins—as a vulnerability in B-cell lymphomas. Her highly cited 2020 work (64 citations) demonstrated that cancer cells often overexpress N-myristoyltransferases (NMTs), making them promising anti-cancer targets. By systematically investigating NMT inhibition, her team established a foundation for developing novel therapies that disrupt critical membrane signaling in malignant cells. Dr. Postovit’s research has significantly advanced our understanding of how post-translational modifications drive oncogenic signaling, earning her recognition as a leader in translational cancer biology. Her work continues to shape therapeutic strategies aimed at exploiting metabolic and lipid-dependent pathways in aggressive cancers, with profound implications for improving patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Targeting N-myristoylation for therapy of B-cell lymphomas
64 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: University of Alberta

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago